200 related articles for article (PubMed ID: 37735702)
1. Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature.
Chang Y; Shan X; Ge Y
Pediatr Rheumatol Online J; 2023 Sep; 21(1):106. PubMed ID: 37735702
[TBL] [Abstract][Full Text] [Related]
2. Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels.
Wakiguchi H; Hasegawa S; Hirano R; Kaneyasu H; Wakabayashi-Takahara M; Ohga S
Pediatr Rheumatol Online J; 2015 Nov; 13():49. PubMed ID: 26581448
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 5 cases of dermatomyositis complicated with macrophage activation syndrome].
Xing XY; Zhang JX; Zhu FY; Wang YF; Zhou XY; Li YH
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1214-1218. PubMed ID: 36533358
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome in juvenile dermatomyositis: a systematic review.
Poddighe D; Dauyey K
Rheumatol Int; 2020 May; 40(5):695-702. PubMed ID: 31529231
[TBL] [Abstract][Full Text] [Related]
5. Hepatic veno-occlusive disease accompanied by thrombotic microangiopathy developed during treatment of juvenile dermatomyositis and macrophage activation syndrome: A case report.
Mouri M; Kanamori T; Tanaka E; Hiratoko K; Okubo M; Inoue M; Morio T; Shimizu M; Nishino I; Okiyama N; Mori M
Mod Rheumatol Case Rep; 2023 Jun; 7(2):404-409. PubMed ID: 36416547
[TBL] [Abstract][Full Text] [Related]
6. Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review.
Stewart JA; Price T; Moser S; Mullikin D; Bryan A
Pediatr Rheumatol Online J; 2022 Feb; 20(1):16. PubMed ID: 35193600
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children.
Wang X; Ding Y; Zhou Z; Hou J; Xu Y; Li J
Pediatr Rheumatol Online J; 2021 Jan; 19(1):6. PubMed ID: 33407621
[TBL] [Abstract][Full Text] [Related]
8. Hemophagocytosis in Cutaneous Autoimmune Disease.
Kerl K; Wolf IH; Cerroni L; Wolf P; French LE; Kerl H
Am J Dermatopathol; 2015 Jul; 37(7):539-43. PubMed ID: 25062264
[TBL] [Abstract][Full Text] [Related]
9. Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis.
Vuppala A; Sondhi M; Umer S
Pediatr Rheumatol Online J; 2023 Dec; 21(1):147. PubMed ID: 38124190
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.
Xu Y; Ma X; Zhou Z; Li J; Hou J; Zhu J; Kang M; Lai J; Li X
Pediatr Rheumatol Online J; 2021 Jan; 19(1):2. PubMed ID: 33407602
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activation syndrome in adult dermatomyositis: a case-based review.
Kishida D; Sakaguchi N; Ueno KI; Ushiyama S; Ichikawa T; Yoshinaga T; Shimojima Y; Sekijima Y
Rheumatol Int; 2020 Jul; 40(7):1151-1162. PubMed ID: 32356114
[TBL] [Abstract][Full Text] [Related]
12. Clinical analysis of macrophage activation syndrome in adult rheumatic disease: A multicenter retrospective study.
Ke Y; Lv C; Xuan W; Wu J; Da Z; Wei H; Zhang M; Tan W
Int J Rheum Dis; 2020 Nov; 23(11):1488-1496. PubMed ID: 32885598
[TBL] [Abstract][Full Text] [Related]
13. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
[No Abstract] [Full Text] [Related]
14. Hemophagocytic lymphohistiocytosis complicated by central nervous system lesions in a patient with dermatomyositis: a case presentation and literature review.
Yamashita H; Matsuki Y; Shimizu A; Mochizuki M; Takahashi Y; Kano T; Mimori A
Mod Rheumatol; 2013 Mar; 23(2):386-92. PubMed ID: 22576792
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of macrophage activation syndrome in adult dermatomyositis: A single-center retrospective case-control study.
Zhu D; Ying S; Yang C; Li S; Tang S; Sun C; Fang H; Qiao J
Immun Inflamm Dis; 2024 Jan; 12(1):e1141. PubMed ID: 38270325
[TBL] [Abstract][Full Text] [Related]
16. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
Quintana-Ortega C; Remesal A; Ruiz de Valbuena M; de la Serna O; Laplaza-González M; Álvarez-Rojas E; Udaondo C; Alcobendas R; Murias S
Mod Rheumatol Case Rep; 2021 Jan; 5(1):101-107. PubMed ID: 33019894
[TBL] [Abstract][Full Text] [Related]
17. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.
Lin CI; Yu HH; Lee JH; Wang LC; Lin YT; Yang YH; Chiang BL
Clin Rheumatol; 2012 Aug; 31(8):1223-30. PubMed ID: 22615046
[TBL] [Abstract][Full Text] [Related]
18. Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature.
Sefsafi Z; Hasbaoui BE; Kili A; Agadr A; Khattab M
Pan Afr Med J; 2018; 29():75. PubMed ID: 29875956
[TBL] [Abstract][Full Text] [Related]
19. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
Xia J; Jiang G; Jin T; Shen Q; Ma Y; Wang L; Qian L
BMC Pediatr; 2021 Nov; 21(1):488. PubMed ID: 34732158
[TBL] [Abstract][Full Text] [Related]
20. [The analysis of clinical phenotypes and autoantibodies in juvenile dermatomyositis].
Li DM; Wang L; Liu MY; Xu L; Tang XM
Zhonghua Er Ke Za Zhi; 2020 Dec; 58(12):966-972. PubMed ID: 33256317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
